Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-NK”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05842707
What this trial is testing

Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Who this might be right for
Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Aibin Liang，MD，Ph.D. 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04033302
What this trial is testing

Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Very early researchLooking for participantsNCT07283315
What this trial is testing

Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases

Who this might be right for
Paediatric B Cell-related Autoimmune DiseasesAutoimmune DiseasesCAR
The Children's Hospital of Zhejiang University School of Medicine 12
Testing effectiveness (Phase 2)WithdrawnNCT05570188
What this trial is testing

Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies

Who this might be right for
B-cell LymphomaB-cell Leukemia
Kunming Hope of Health Hospital
Testing effectiveness (Phase 2)Temporarily pausedNCT05703854
What this trial is testing

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced MesotheliomaAdvanced Osteosarcoma
M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT05563545
What this trial is testing

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Shanghai Simnova Biotechnology Co.,Ltd. 2
Early research (Phase 1)Looking for participantsNCT07444632
What this trial is testing

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

Who this might be right for
LymphoidHodgkin Lymphoma
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05922930
What this trial is testing

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

Who this might be right for
Pancreatic CancerOvarian CancerAdenocarcinoma
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06631040
What this trial is testing

Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

Who this might be right for
Acute Lymphocytic Leukemia in Relapse
Shahid Beheshti University of Medical Sciences 10
Early research (Phase 1)Active Not RecruitingNCT04526834
What this trial is testing

Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaPeripheral T Cell LymphomaExtranodal NK/T-cell Lymphoma+2 more
Tessa Therapeutics 21
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Early research (Phase 1)Not Yet RecruitingNCT07031011
What this trial is testing

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

Who this might be right for
Advanced Gastric or Colorectal Cancer
jiuwei cui 22
Not applicableUnknownNCT05776355
What this trial is testing

NKG2D CAR-NK & Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hangzhou Cheetah Cell Therapeutics Co., Ltd 18
Testing effectiveness (Phase 2)Looking for participantsNCT03882840
What this trial is testing

Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

Who this might be right for
Anti-cancer Cell ImmunotherapyT Cell and NK Cell
Second Affiliated Hospital of Guangzhou Medical University 60
Early research (Phase 1)Not Yet RecruitingNCT07631013
What this trial is testing

Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions

Who this might be right for
Squamous Cell Carcinoma
M.D. Anderson Cancer Center 36
Early research (Phase 1)UnknownNCT05667155
What this trial is testing

Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Early research (Phase 1)Looking for participantsNCT05472558
What this trial is testing

Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 48
Early research (Phase 1)Active Not RecruitingNCT04288726
What this trial is testing

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeClassical Hodgkin Lymphoma
Baylor College of Medicine 27
Early research (Phase 1)Active Not RecruitingNCT06255028
What this trial is testing

CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisIdiopathic Inflammatory Myopathies+1 more
Century Therapeutics, Inc. 6
Testing effectiveness (Phase 2)WithdrawnNCT03579927
What this trial is testing

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Who this might be right for
CD19 PositiveMantle Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma+4 more
M.D. Anderson Cancer Center
Next Page